Bromwich E, McMillan D C, Lamb G W A, Vasey P A, Aitchison M
University Department of Surgery, Royal Infirmary, Glasgow, G31 2ER, UK.
Br J Cancer. 2004 Oct 4;91(7):1236-8. doi: 10.1038/sj.bjc.6602152.
The prognostic value of C-reactive protein, compared with ECOG performance status (ECOG-ps), in patients receiving alpha-interferon treatment for advanced renal cancer was assessed in 58 patients. In all, 55 patients died on follow-up. On multivariate analysis with ECOG-ps and C-reactive protein entered as covariates, only C-reactive protein was a significant independent predictor of survival (HR 2.03, 95% CI 1.09-3.80, P=0.026).